Gastric Signet-ring Cell Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2017-11-28
Clinical Trial Update: XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma [Phase 3]
Phase 3 trial comparing XELOX plus Apatinib against XELOX alone as postoperative chemotherapy for locally advanced gastric signet-ring cell …